As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.

It’s time to go back to basics when it comes to pharmaceutical supply chains and preventing shortages.

Experts from Lonza share how biologics and CGT can recognize the gaps and similarities that can be utilized to optimize cell culture media challenges.

The latest X-ray technology goes beyond foreign body detection, ensuring each dose is right first time – every time.

Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.

Anna Codina from Bruker BioSpin discusses the Biosecure Act and how outsourcing could be affected.

How the pharma industry can help tackle the opioid crisis and advance treatments

The highlights of the trade show and its conference agenda - day 3

How whole genome sequencing is being used to understand the bacterium that causes syphilis – and what it means for vaccine development.